Optometric Management Special Edition

2015

Issue link: https://optometricmanagementsupplements.epubxp.com/i/587112

Contents of this Issue

Navigation

Page 23 of 59

22 S P E C I A L E D I T I O N 2 0 1 5 • O P T O M E T R I C M A N A G E M E N T . C O M OPTOME TRIC MANAGEMENT FE ATURE NEW EVIDENCE MAKES US RETHINK DEPOSITION AND ITS CLINICAL RELEVANCE IN OUR EVERYDAY PRACTICE PROTEIN DEPOSITION: PERCEPTION VS. REALITY David Ruston, F.C.Optom, Dip.C.L.P., F.A.A.O. N O SINGLE LENS MATERIAL or design will suit every patient. Ocular physiology, patients' lifestyle needs and clini- cal signs and symptoms all play signifcant roles in contact lens selection. For many practitioners, tried and true hydrogel mate- rials, such as etaflcon A, are still a great option for their daily disposable patients. Now new evidence is coming in about how benefcial proteins like lysozyme § interact with some of these materials, such as etaflcon A and other group IV hydrogels, and may help explain why these materials have stood the test of time. 1 THE ROLE OF LYSOZYME Lysozyme, a protein produced by the lacrimal gland, is the most com- mon protein deposited on contact lenses. It is present in tears in large quantities, accounting for approxi- mately 40% of all of the proteins found in the tear flm. 2,3 In its native state, this positively- charged protein works as part of the eye's natural defense mechanism. But, when a contact lens is placed on the eye, the structural integrity of lyso- zyme can be compromised, causing it to change its structure and lose its function. Tis alteration to the pro- tein is referred to as denaturation. Denatured lysozyme has been linked to immunological responses through in vitro studies. Recent- ly, through research done at the Center for Contact Lens Research at the University of Waterloo by Pro- fessor Lyndon Jones and his team using cultured human corneal epithe- lial cells, it has been shown that the denatured protein lysozyme also triggers the release of infammatory biomarkers. §4 Tis might be one rea- son why some contact lenses lead to irritation and, subsequently, to un- comfortable wear. THE VALUE OF ACTIVE LYSOZYME FOR SUCCESSFUL CONTACT LENS WEAR Te challenge with lens wear is not keeping lysozyme out — it is keeping it in its native state. In fact, it is well documented in a num- ber of studies that lysozyme is benef- cial in the tear flm and is part of the eye's innate defense system. 5,6 Lysozyme is a small, positively charged protein that tends to be at- tracted in very high quantities to negatively charged high water con- tent ionic (group IV) materials like etaflcon A. A KEY TO HIGH PERFORMANCE In fact, the chemistry of etaflcon A allows for the majority of lyso- zyme to penetrate into the bulk of the lens where it stays in its natural form and does not undergo structural changes. 7,8 Tis means that for 1-DAY ACUVUE MOIST wearers, lysozyme may not be the enemy. In fact, the ability of etaflcon A to help keep this protein in its natural state may be a contributing factor to the high perfor- mance of the lens. MORE KNOWLEDGE With more knowledge about etaflcon A and its interaction with lysozyme, we can continue to rely on it as an excellent choice for discomfort-prone patients — spheri- cal, astigmatic, and presbyopic — who would beneft from a lens that helps keep moisture in and irritation out. OM Spotlight on Science

Articles in this issue

Links on this page

Archives of this issue

view archives of Optometric Management Special Edition - 2015